Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher?
The company has one marketed drug, Korlym, used to treat high blood sugar (hyperglycemia) caused by high cortisol levels in the blood (hypercortisolism) in adults with endogenous Cushing's syndrome ...
The Mirror US on MSN22h
White woman's skin turns black after cells get 'confused' by rare conditionsSabrina Gomes was diagnosed with Cushing's syndrome and a tumor in her thymus gland which has caused her skin color to change ...
Monday, November 4, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback